Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Medicine, Multiple sclerosis, Internal medicine, Cladribine, Expanded Disability Status Scale, and Alemtuzumab.
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study
Effectiveness and Tolerability of Ofatumumab Versus First-line DMTs in Early RMS Patients: Phase 3b STHENOS Study Design
HAL (Le Centre pour la Communication Scientifique Directe) 2021cited by 0position: middle
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study
FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine